Vittoria Colizza
Research Director
INSERM and Sorbonne Université, Faculté de Mèdecine, Paris, France
Tokyo Institute of Technology, World Research Hub Initiative, Tokyo, Japan |
short bioVittoria Colizza completed her undergraduate studies in Physics at the University of Rome Sapienza, Italy, in 2001 and received her PhD in Statistical and Biological Physics at the International School for Advanced Studies in Trieste, Italy, in 2004. She then spent 3 years at the Indiana University School of Informatics in Bloomington, IN, USA, first as a post-doc and then as a Visiting Assistant Professor. In 2007 she joined the ISI Foundation in Turin, Italy, where she started a new lab after being awarded a Starting Independent Career Grant in Life Sciences by the European Research Council Ideas Program (more info on the EpiFor project webpage). In 2011 Vittoria joined the INSERM (French National Institute for Health and Medical Research) in Paris where she leads the EPIcx lab within the Equipe 1 Surveillance and modeling of communicable diseases of the Pierre Louis Institute of Epidemiology and Public Health (IPLESP). She works on the characterization and modeling of the spread of emerging infectious diseases, by integrating methods of complex systems with statistical physics approaches, computational sciences, geographic information systems, and mathematical epidemiology. In 2017 she was promoted Research Director at INSERM. Since 2020, she is also Visiting Professor at Tokyo Institute of Technology.
research activitiesColizza's work is centered in the development of data-driven mathematical and computational models to solve problems of infectious disease dynamics and public health. Using large-scale data characterizing contacts, behaviors, and mobility of hosts from a variety of sources and sensors (face-to-face interactions, contact matrices, commuting, air travel, migrations, trade movements, call detail records from mobile phones, etc.), her research explores how disease diffusion in space is shaped by hosts' behavior. Applications range from human epidemics (e.g. 2009 H1N1 pandemic influenza, MERS-CoV epidemic, Ebola virus disease epidemic, seasonal flu, AMR pathogens, COVID-19 pandemic) to animal epidemics (e.g. bovine brucellosis and tuberculosis, bovine viral diarrhea, rabies in dogs and bats), to gather context epidemic awareness and provide risk assessment analyses for preparedness, mitigation, and control. Colizza also leads the digital surveillance effort for influenza-like-illness in France (Grippenet.fr). Since January 2020, her lab is fully involved in the response to COVID-19 pandemic to inform authorities in the management of the health crisis.
honors and awards
boards and memberships
|
